Gastric cancer

What Is Gastric Cancer?

Gastric cancer, also called stomach cancer, develops when abnormal cells within the lining of the stomach begin growing uncontrollably, potentially spreading deeper into the stomach wall and, in more advanced cases, to nearby lymph nodes and distant organs.¹

Chronic infection with a bacterium called Helicobacter pylori represents the leading cause of gastric cancer worldwide, responsible for an estimated seventy five percent of cases, making it one of the most significant infection related cancer risks identified to date.¹

Because early gastric cancer frequently produces few or no symptoms, the disease is often diagnosed only after it has progressed to a more advanced stage, underscoring the importance of understanding risk factors and addressing chronic stomach symptoms with medical evaluation.²

Chronic infection with Helicobacter pylori is a major risk factor for stomach cancer, responsible for an estimated seventy five percent of gastric cancer cases worldwide.
National Cancer Institute

Symptoms

Most patients with early gastric cancer experience no symptoms at all, and when symptoms do appear, they tend to be vague and nonspecific, often overlapping with far more common, benign digestive complaints.²

Early symptoms, when present, can include upper abdominal pain, a sense of fullness after eating, poor appetite, and vomiting.²

Weight loss and abdominal pain often represent later signs of disease progression, sometimes accompanied by dark, tarry stools or vomiting blood, both of which reflect bleeding within the digestive tract and warrant prompt medical attention.²

Causes

Chronic Helicobacter pylori infection stands as the dominant identified cause of gastric cancer, spreading between people through direct contact with saliva, vomit, or stool, and often persisting for years without causing noticeable symptoms.¹

Many people with chronic Helicobacter pylori infection develop stomach ulcers or a form of chronic inflammation called atrophic gastritis, which can eventually progress toward cancer over an extended period.¹

Certain strains of Helicobacter pylori produce a toxin that directly promotes cancer development by disrupting normal controls on cell growth and increasing the ability of affected cells to spread, helping explain why infection with specific bacterial strains carries particularly elevated risk.¹

Risk Factors

Beyond Helicobacter pylori infection, smoking represents a well established risk factor for gastric cancer, with people who smoke facing meaningfully higher risk compared to nonsmokers.¹

Dietary patterns also influence risk, with diets low in fruits and vegetables or high in salted, smoked, or poorly preserved foods associated with increased likelihood of developing gastric cancer.¹

Host genetic factors, along with the composition of an individual’s gut microbiota, appear to further influence both cancer risk and clinical outcomes, reflecting the multifactorial nature of gastric cancer development.³

Complications

As gastric cancer advances, it can invade progressively deeper layers of the stomach wall and eventually spread to nearby lymph nodes, a key factor influencing both staging and prognosis.⁴

Advanced disease can also spread to distant organs, and overall survival differs dramatically based on the stage at diagnosis, with early stage disease carrying a substantially better prognosis than cancer discovered at a more advanced stage.⁵

Complications related to bleeding, obstruction of food passage, and malnutrition can all develop as gastric tumors grow, contributing significantly to symptom burden in patients with more advanced disease.

Treatment

Surgical removal of part or all of the stomach, combined with removal of nearby lymph nodes, remains the gold standard treatment approach for gastric cancer when the disease is caught at a stage where curative surgery remains possible.⁴

For more advanced disease, combining surgery with chemotherapy given before the operation, along with targeted therapy or immunotherapy in appropriate cases, represents the main treatment approach, since chemotherapy or radiation alone have not been shown to meaningfully improve survival.⁴

Accurate staging through imaging and pathology evaluation plays an essential role in guiding treatment decisions, since the appropriate combination of surgery, chemotherapy, and other therapies depends heavily on how far the cancer has spread at diagnosis.⁴

Prevention

Testing for and treating Helicobacter pylori infection has been shown to meaningfully reduce the risk of developing gastric cancer, making infection management one of the most direct, evidence based prevention strategies available.¹

Avoiding smoking and following a diet rich in fruits and vegetables while limiting salted, smoked, and poorly preserved foods further support gastric cancer prevention.¹

Given how often early gastric cancer produces no symptoms, prompt evaluation of persistent digestive symptoms, particularly among people with known risk factors, remains an important part of catching the disease at an earlier, more treatable stage.²

Why Visual Communication Matters for Gastric Cancer

Explaining how a common bacterial infection can, over years, progress toward cancer requires visuals that make this slow, largely invisible process understandable, helping patients grasp why testing and treatment for infection matter so much.

Pharmaceutical companies, oncology practices, and patient education organizations rely on clear illustration and animation to explain gastric cancer biology and support informed treatment decisions.

• Illustrating how Helicobacter pylori infection contributes to cancer development
• Animating the progression from chronic gastritis to gastric cancer
• Explaining surgical approaches, including partial and total gastrectomy
• Visualizing how staging influences treatment selection and prognosis
• Supporting patient education on symptom recognition and screening
• Creating training materials for oncology and gastroenterology clinicians

How Biotic Artlab Supports Gastric Cancer Communication

We work with pharmaceutical companies, oncology practices, and patient advocacy organizations to create scientifically accurate visuals that make gastric cancer and its treatment easier to understand.

• Custom 3D animations of Helicobacter pylori infection and gastric tissue changes
• Detailed illustrations of gastrectomy procedures and lymph node dissection
• Treatment pathway animations covering chemotherapy, surgery, and targeted therapy
• Patient facing materials on symptom recognition and risk reduction
• Clinical training content for oncology, gastroenterology, and surgical teams
• Conference presentations and marketing visuals for digestive cancer audiences

Frequently Asked Questions

What is the leading cause of gastric cancer?

Chronic infection with Helicobacter pylori is the leading identified cause, responsible for an estimated seventy five percent of gastric cancer cases worldwide.¹

Does gastric cancer cause early symptoms?

Usually not. Most patients with early gastric cancer are asymptomatic, and symptoms that do appear are often vague and nonspecific.²

Can treating H pylori prevent stomach cancer?

Yes, testing for and treating Helicobacter pylori infection has been shown to meaningfully reduce gastric cancer risk.¹

What is the main treatment for gastric cancer?

Surgical removal of the affected portion of the stomach along with nearby lymph nodes remains the gold standard for curative treatment when caught early enough.⁴

How does stage affect gastric cancer prognosis?

Survival differs dramatically by stage, with early stage disease carrying a substantially better prognosis than cancer diagnosed at a more advanced stage.⁵

What dietary factors raise gastric cancer risk?

Diets low in fruits and vegetables or high in salted, smoked, or poorly preserved foods are associated with increased gastric cancer risk.¹

Have a Project in Mind? Contact Us.

If you are developing patient education materials, clinical training content, or marketing visuals related to gastric cancer or digestive oncology, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Cancer Institute. Stomach Cancer Causes and Risk Factors.
2. National Center for Biotechnology Information. Recent Advances in the Diagnosis, Staging, Treatment, and Prognosis of Advanced Gastric Cancer.
3. National Center for Biotechnology Information. Surgical Treatment of Gastric Adenocarcinoma, What Factors Influence the Prognosis.
4. National Center for Biotechnology Information. Surgical Treatment and Prognosis of Gastric Cancer in 2613 Patients.
5. National Cancer Institute. Helicobacter Pylori and Cancer.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.